GCMG vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GCMG presents a complex profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between its Graham Number ($2.05) and Intrinsic Value ($12.39). While the company exhibits explosive earnings growth (104.4% YoY) and an attractive forward P/E of 9.22, these strengths are offset by a critical dividend payout ratio of 107.14%, indicating an unsustainable yield. Technicals are currently heavily bearish (0/100), suggesting the market is discounting the strong earnings surprises in favor of broader sector headwinds or balance sheet concerns.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
GCMG vs JPM: Head-to-Head Comparison
This page compares GCM Grosvenor Inc. (GCMG) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.